Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women

High Blood Pressure and Cardiovascular Prevention

Volumn 19, Issue 1, 2012, Pages 33-39

  Salvetti, Guido ^a   Pucci, Andrea ^a   Fierabracci, Paola ^a   Ceccarini, Giovanni ^a   Palagi, Caterina ^a   Donne, Maria Grazia Delle ^a   Di Bello, Vitantonio ^a   Piaggi, Paolo ^a   Vitti, Paolo ^a   Salvetti, Antonio ^a   Pinchera, Aldo ^a   Santini, Ferruccio ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Hypertension; Left ventricular hypertrophy; Left ventricular mass; Metabolic syndrome; Obesity

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY SURFACE; BODY WEIGHT; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; OBSERVATIONAL STUDY; PREVALENCE; PRIORITY JOURNAL; PULSE PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADIPOSITY; ADULT; AGE FACTORS; AGED; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; COMORBIDITY; DIABETES MELLITUS; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; ITALY; LINEAR MODELS; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; WAIST CIRCUMFERENCE; WAIST-HIP RATIO; YOUNG ADULT;

EID: 84861950539     PISSN: 11209879     EISSN: 11791985     Source Type: Journal    
DOI: 10.2165/11593700-000000000-00000     Document Type: Article

References (30)

1. Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 2008; 32: 1431-7
2. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 122: 1106-14
3. de Simone G, Wachtell K, Palmieri V, et al. Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study. Circulation 2005; 111: 1924-31 (Pubitemid 40570211)
4. Prospective Studies Collaboration, Whitlock G, Lewington S, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet 2009; 373: 1083-96
5. Wilson PW, D'Agostino RB, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867-72
6. Bogers RP, Bemelmans WJ, Hoogenveen RT, et al., for the BMI-CHD Collaboration Investigators. Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300 000 persons. Arch Intern Med 2007; 167: 1720-8 (Pubitemid 47403058)
7. de Simone G, Devereux RB, Roman MJ, et al. Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 1994; 23: 600-6 (Pubitemid 24129354)
8. Devereux RB, Wachtell K, Gerdts E, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004; 292: 2350-6 (Pubitemid 39491919)
9. de Simone G, Gottdiener JS, Chinali M, et al. Left ventricular mass predicts heart failure not related to previous myocardial infarction: the Cardiovascular Health Study. Eur Heart J 2008; 29: 741-7 (Pubitemid 351431013)
10. Bombelli M, Facchetti R, Carugo S, et al. Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values. J Hypertens 2009; 27: 2458-64
11. Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press 2009; 18: 308-47
12. Grassi G, Diez J. Obesity-related cardiac and vascular structural alterations: beyond blood pressure overload. J Hypertens 2009; 27: 1750-2
13. Norton GR, Majane OH, Libhaber E, et al. The relationship between blood pressure and left ventricular mass index depends on an excess adiposity. J Hypertens 2009; 27: 1873-83
14. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-7
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97
16. de Simone G, Kizer JR, Chinali M, et al. Strong Heart Study Investigators. Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. Am J Hypertens 2005; 18:191-6 (Pubitemid 40332548)
17. Chirinos JA, Segers P, De Buyzere ML, et al. Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension 2010; 56: 91-8
18. de Simone G, Devereux RB. Method errors or unexplained biological information? Hypertension 2010; 56: e177-8
19. Mancia G, Bombelli M, Corrao G, et al. Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis. Hypertension 2007; 49: 40-7 (Pubitemid 46360339)
20. de Simone G, Devereux RB, Chinali M, et al. Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the Strong Heart Study. Nutr Metab Cardiovasc Dis 2009; 19: 98-104
21. Redon J, Cifkova R, Laurent S, et al. Scientific Council of the European Society of Hypertension. The metabolic syndrome in hypertension: European Society of Hypertension position statement. J Hypertens 2008; 26: 1891-900
22. Casiglia E, Tikhonoff V, Caffi S, et al. Menopause does not affect blood pressure and risk profile, and menopausal women do not become similar to men. J Hypertens 2008; 26: 1983-92
23. Lieb W, Xanthakis V, Sullivan LM, et al. Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the Framingham Offspring Study. Circulation 2009; 119: 3085-92
24. de Simone G, Devereux RB, Palmieri V, et al., HyperGEN Study. Influence of fat-free mass on detection of appropriateness of left ventricular mass: the HyperGEN Study. J Hypertens 2003; 21: 1747-52 (Pubitemid 37076359)
25. Jennings G. Obesity and left ventricular hypertrophy: does my heart look big on this? J Hypertens 2010; 28: 2190-3
26. Alpert MA, Lambert CR, Panayiotou H, et al. Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss. Am J Cardiol 1995; 76: 1194-7
27. Salvetti G, Santini F, Versari D, et al. Fat distribution and cardiovascular risk in obese women. Obes Metab Milan 2008; 4: 202-7
28. Yusuf S, Hawken S, Ounpuu S, et al., INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27, 000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-9
29. Rutter MK, Parise H, Benjamin EJ, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation 2003; 107: 448-54 (Pubitemid 36158048)
30. Devereux RB, Roman MJ, Paranicas M, et al. Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation 2000; 101: 2271-6 (Pubitemid 30317129)